Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.81 USD | -1.16% | -2.10% | -12.53% |
May. 07 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
May. 07 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 50.11M | Sales 2025 * | 52.04M | Capitalization | 1.88B |
---|---|---|---|---|---|
Net income 2024 * | -402M | Net income 2025 * | -432M | EV / Sales 2024 * | 21.8 x |
Net cash position 2024 * | 786M | Net cash position 2025 * | 376M | EV / Sales 2025 * | 28.9 x |
P/E ratio 2024 * |
-5.04
x | P/E ratio 2025 * |
-5.04
x | Employees | 346 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.48% |
Latest transcript on Beam Therapeutics Inc.
1 day | -1.16% | ||
1 week | -2.10% | ||
Current month | -0.04% | ||
1 month | +12.21% | ||
3 months | -39.71% | ||
6 months | -15.21% | ||
Current year | -12.53% |
Managers | Title | Age | Since |
---|---|---|---|
John Evans
CEO | Chief Executive Officer | 46 | 16-12-31 |
President | 55 | 18-01-31 | |
Director of Finance/CFO | 47 | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Graham Cooper
BRD | Director/Board Member | 54 | 19-10-09 |
John Maraganore
BRD | Director/Board Member | 60 | 21-11-04 |
Mark Fishman
BRD | Director/Board Member | 73 | 18-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
8.03% | 2 M€ | -25.75% | ||
4.10% | 0 M€ | -.--% | - | |
4.00% | 1 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 23.82 | -1.12% | 948,776 |
24-05-30 | 24.09 | +1.73% | 1,224,381 |
24-05-29 | 23.68 | -2.23% | 845,182 |
24-05-28 | 24.22 | -0.41% | 755,403 |
24-05-24 | 24.32 | +1.29% | 385,361 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.53% | 1.88B | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- BEAM Stock